Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01880437
Title A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myleodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA | DEU | CAN

Facility Status City State Zip Country Details
Stanford California 94305 United States Details
Ann Arbor Michigan 48109 United States Details
Kansas City Missouri 64131 United States Details
New York New York 10065 United States Details
Houston Texas 77030 United States Details
Edmonton Alberta T6L5X8 Canada Details
Toronto Ontario M5G 2M9 Canada Details
Montreal Quebec H1T 2M4 Canada Details
Montreal Quebec H3T 1E2 Canada Details
Braunschweig 38114 Germany Details
Essen 45122 Germany Details
Hamburg 20246 Germany Details
Heidelberg 69120 Germany Details
Münster 48149 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field